CasLoc logo
All Cases PTAB Litigations UPC Oppositions

BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc.

1:16-cv-01303

Overview

Case Number 1:16-cv-01303
Filing Date 2016-12-22
Status Terminated
Termination Date 2018-02-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

3 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Julia M. Johnson

Email: jmjohnson@winston.com

Michael A. Meneghini

Email: mmeneghini@winston.com

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

1 Attorneys Listed

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Endo Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Arius Two, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

BioDelivery Sciences International, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 1 U.S. Courts: 2
USPTO PTAB Trial 2014-01-22
IPR2014-00376

MONOSOL RX, LLC v. Arius Two, Inc. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2017-03-16
1:17-cv-00282

BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-03-18
1:16-cv-00175

BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7579019
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
Filed: 2005-03-01
Issued: 2009-08-25
Expired (Term Ended)
Expires: 2021-01-19
US8147866
Transmucosal delivery devices with enhanced uptake
Filed: 2011-07-15
Issued: 2012-04-03
Active (4.6 yrs remaining)
Expires: 2031-07-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 3 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
Remark - The Markman Hearing set for Tuesday, February 20, 2018 has been removed from the court's calendar. (mdb)
Entry #β€” • 2018-01-31
Procedural / Extension Motion Pending
SO ORDERED - re 20 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to April 14, 2017 filed by BioDelivery Sciences Internationa...
Entry #β€” • 2017-04-03
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to April 14, 2017 - filed by Arius Two, Inc., BioDelivery Sciences Internationa...
Entry #20 • 2017-03-30 Document →
Claim Construction / Markman Filing Pending
SO ORDERED - re 16 Proposed Scheduling Order: Case referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and/or Ame...
Entry #β€” • 2017-03-21
Claim Construction / Markman Filing Pending
ORAL ORDER re 13 Joint Status Report - The parties' proposed schedule is ADOPTED-IN-PART with the following changes: The Markman Hearing (2 hours) is set for 2/...
Entry #β€” • 2017-03-16

Docket Entries

(61 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2053842.) - filed by BioDelivery Sciences International, Inc., Arius Two, Inc., Endo Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A & B, # 2 Civil Cover Sheet)(rwc) (Entered: 12/24/2016)

Entry #1 • 2016-12-22
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 12/24/2016)

Entry #2 • 2016-12-22
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ATTACHED FORM. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 1/22/2020 & 7/23/27. (rwc) (Entered: 12/24/2016)

Entry #3 • 2016-12-22
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,019 B2; 8,147,866 B2. (rwc) (Entered: 12/24/2016)

Entry #4 • 2016-12-22
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Endo Pharmaceuticals, Inc.; Corporate Parent BioDelivery Sciences International, Inc. for Arius Two, Inc. filed by Arius Two, Inc., Endo Pharmaceuticals, Inc.. (rwc) (Entered: 12/24/2016)

Entry #5 • 2016-12-22
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc